Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BBSRC is Major Partner in Europe-wide Synthetic Biology Funding

Published: Tuesday, May 14, 2013
Last Updated: Tuesday, May 14, 2013
Bookmark and Share
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.

The call is the first from the Synthetic Biology ERA-NET (ERASynBio) - a project designed to enhance European Synthetic Biology research through joint policy making, community building and training, and transnational funding.

BBSRC, along with 12 other ERASynBio funding agencies from Europe and the USA will support around €15M of research into this emerging field. The call represents a unique opportunity to build global Synthetic Biology capacity through innovative transnational projects.

The funding will allow European and US researchers to come together to work on high impact, high reward projects and address Synthetic Biology challenges which cannot be tackled at a national level.

Douglas Kell, BBSRC Chief Executive, said: "Synthetic biology has the potential to address some of the major challenges of the 21st Century as well as offering innovations to benefit the economy. By applying engineering principles to biological research we have the potential to shape the future of industrial compounds, biofuels and new medicines, and to provide exciting insights into fundamental biological mechanisms."

BBSRC's major involvement in this first funding call from ERASynBio highlights commitment and progress towards the UK building its leading international role in Synthetic Biology, as recommended in "A Synthetic Biology Roadmap for the UK" published in 2012.

Lionel Clarke of Shell Projects and Technology, who chaired the coordinating group for the roadmap, said: "International collaboration is essential to enhance research opportunities and make meaningful progress in this area. BBSRC's major involvement in this European project highlights the UK as a centre of international excellence taking a leading role in synthetic biology research.

ERASynBio describes Synthetic Biology as the engineering of biology: the deliberate (re)design and construction of novel biological and biologically based systems to perform new functions for useful purposes, that draws on principles elucidated from biology and engineering.

In the near future, Synthetic Biology could open doors to a more efficient processing and non-polluting manufacturing of fine chemicals and pharmaceuticals, and new routes for the generation of biofuels. However the long term potential of this emerging field can only be realised through strategic international cooperation.

ERASynBio welcomes multidisciplinary research proposals from a range of scientific areas including: metabolic engineering; regulatory circuits; orthogonal biosystems; bionanoscience; minimal genomes; protocells.

These applications have the potential to contribute to sectors including: industrial biotechnology, bioenergy, biomedicine, biosensors, bioremediation, agriculture and new tools for scientific research.

The new funding will provide an evolving line of European transnational projects and facilitate the identification of barriers in Synthetic Biology.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Way to Improve Antibiotic Production
A discovery has been made which could make it easier to scale up antibiotic production for commercialisation.
Tuesday, June 18, 2013
H7N9: A Novel Influenza Virus and it’s Control
Whilst the virus remains as one primarily circulating in birds, breaking this cycle of replication is the only effective response to its control.
Thursday, May 09, 2013
BBSRC Supports Call for Multi-Disciplinary Research Centres in Synthetic Biology
Up to six centres will be funded in two phases; three in this financial year and three next financial year.
Friday, May 03, 2013
Vaccine Production in Plants Nets Scientist Innovator of the Year 2012
Innovation could allow quicker vaccine development to combat pandemics.
Friday, March 30, 2012
Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
HIV Structure Stabilized
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Anthrax Vaccine Protects Monkeys
Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—completely protected monkeys from lethal anthrax infection, according to a recently published study.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Plant-Based Vaccine Among Front Runners In Search For New Polio Jab
A researcher from Norwich is part of a consortium that has been awarded $1.5 million to develop safer polio vaccines, using a new technique developed at the John Innes Centre.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!